Pritelivir

DRUG3 trials

Sponsors

AiCuris Anti-infective Cures AG

Conditions

HSVHSV Infection

Phase 1

Potential Influence of Esomeprazole on the Pharmacokinetics of Pritelivir

CompletedNCT05513625

AiCuris Anti-infective Cures AGHSV Infection

Start: 2020-07-13End: 2020-10-13Updated: 2024-02-22

Phase 3

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects

CompletedNCT03073967

AiCuris Anti-infective Cures AGHSV Infection

Start: 2017-05-08End: 2025-11-11Updated: 2026-06-12

Unknown Phase

Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2

AiCuris Anti-infective Cures AGHSV

Updated: 2025-02-10

Related Papers

233. Efficacy and safety results from the Phase 2 clinical trial of pritelivir versus foscarnet for treatment of acyclovir-refractory and/or resistant mucocutaneous HSV infections in immunocompromised subjects

Open Forum Infectious Diseases2026-01-01